Abstract
Pityriasis Rubra Pilaris (PRP) is a rare chronic inflammatory papulosquamous disease. It has variable clinical presentations with six subgroups1. We describe a patient presented with PRP type 1 with altered liver functions and dyslipidemia successfully treated with acitretin. Acitretin is considered first-line therapy2, although it has relative contraindications in patients with altered liver functions and may result in dyslipidemia and liver damage as a complication. Vigilant use of acitretin may be beneficial in a resource-poor setting to treat PRP.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
